Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News on Cancer

Abortion drug could help reduce risk of breast cancer, group of medics says

Stigma around mifepristone is stopping studies, experts in reproductive health claim in Lancet opinion piece

The Guardian - UK

Merck, Pfizer-Backed Therapy Improves Outcomes For Cisplatin-Ineligible Bladder Cancer Patients

On Tuesday, Merck Co. Inc. (NYSE:MRK) released topline results from the Phase 3 KEYNOTE-905 trial (also known as EV-303) in patients with muscle-invasive bladder cancer (MIBC) who are ineligible for cisplatin-based chemotherapy.

Benzinga

IO Biotech's Combo Therapy For Skin Cancer Falls Just Short, Eyes FDA Talks Later This Year

IO Biotech (NASDAQ:IOBT) on Monday released topline results from the pivotal Phase 3 trial of its investigational, immune-modulatory, off-the-shelf therapeutic cancer vaccine, Cylembio (imsapepimut and etimupepimut, adjuvanted).

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Three new cancer drugs approved for use for NHS Scotland

Three new treatments for cancer have been approved for use by the NHS in Scotland ...

The National (Scotland)

The new take-at-home drug that ‘could boost effectiveness of chemotherapy’

New medicine will spare some patients from more aggressive treatments

The Independent UK

‘Game-changing’ cancer vaccine trial to begin on NHS

The jab uses mRNA technology to train the immune system to fight cancerous cells

The Independent UK

Patients to be fast-tracked on to new head and neck cancer vaccine trial

The jab uses mRNA technology to train the immune system to fight cancer.

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

Celcuity Stock Skyrockets On Breakthrough Trial Data For Heavily Pretreated Breast Cancer

Celcuity Inc. (NASDAQ:CELC) stock surged on Monday after the company reported topline results from the PIK3CA wild-type cohort of the Phase 3 VIKTORIA-1 trial, which evaluated gedatolisib plus fulvestrant with and without palbociclib versus fulvestrant.

Benzinga

Alcohol labels should warn of cancer risk, urge health groups

Doctors and health experts have written a letter to Sir Keir Starmer urging the government to tackle a lack of awareness about the links between alcohol consumption and cancer

The Independent UK

Alcohol should have labels warning drinkers of cancer risks, charities say

Health organisations have written to Keir Starmer urging him to force drinks producers to include warnings

The Guardian - UK

Banned in Britain, Still on US Shelves: Jolly Ranchers Pulled Over 'Cancer‑Causing' Ingredients

Jolly Rancher sweets have been pulled from UK shelves over ingredients linked to cancer risk. Here's why the US still allows them and what consumers need to know

International Business Times UK

EPA will revisit Biden-era ban on the last type of asbestos used in US

The Environmental Protection Agency will reconsider a Biden administration ban on the last type of asbestos used in the United States

The Independent UK

UK-wide drug trial hailed as a ‘milestone’ in leukaemia treatment

Combination of two targeted drugs found to produce better outcomes and was more tolerable than chemotherapy

The Guardian - UK

‘Milestone’ treatment could reshape future leukaemia care

The Flair trial found that 94 per cent of patients who received the two targeted drugs were alive with no disease progression after five years

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

New leukaemia treatment hailed as ‘milestone’ for patients

After five years, 94% of patients were alive, with no disease progression.

The Independent UK

NHS green lights ‘Trojan horse’ treatment that attacks cancer cells from inside

One early adopter describes how he was in remission ‘within the first two or three weeks’ after the treatment

The Independent UK

Groundbreaking cancer treatment which ‘destroys tumours with sound’ to be rolled out on NHS

UK regulators hail ‘major step forward’ as histotripsy to be offered to liver cancer patients later this year

The Guardian - UK

UK shortage of critical drug forcing pancreatic cancer patients to skip meals

One pharmacist described scarcity of life-saving Creon as ‘worst stock shortage’ they have dealt with

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

Three-drug therapy helps women with aggressive breast cancer live longer – trial

The treatment could also delay the need for gruelling chemotherapy, according to the trial.

The Guardian - UK

‘Gift of life’: experts hail neck and head cancer breakthrough

Global trial shows immunotherapy drug significantly lowers chance of cancer spreading or returning

The Independent UK

That risk is associated with the pills’ active ingredient, which is known as phenazopyridine hydrochloride.

Evening Standard

EastEnders star Kara Tointon reveals she’s had a double mastectomy

The 41-year-old, who carries the BRCA1 gene, has also had her fallopian tubes removed

The Independent UK

Scientists link skin cancer risk to the clothes you wear this summer

Projections suggest melanoma skin cancer cases will rise again this year to 21,300 cases – highest on record

The Independent UK

You should wear sunscreen even if you have darker skin. Here's why

Skin experts say people of color still need to wear sunscreen

Marie Claire

This Anti-Aging Laser Could Help Fight Skin Cancer

Good skin and good health? NAFL treatments may offer both.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

The Environmental Protection Agency

the University of Leeds

62 stories

CTSI

56 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.